Enhanced anti-glioma efficacy of doxorubicin with BRD4 PROTAC degrader using targeted nanoparticles.
He Y, Zan X, Miao J, Wang B, Wu Y, Shen Y, Chen X, Gou H, Zheng S, Huang N, Cheng Y, Ju Y, Fu X, Qian Z, Zhou P, Liu J, Gao X.
He Y, et al. Among authors: huang n.
Mater Today Bio. 2022 Sep 12;16:100423. doi: 10.1016/j.mtbio.2022.100423. eCollection 2022 Dec.
Mater Today Bio. 2022.
PMID: 36157053
Free PMC article.